Key Takeaways
- • Anduril Industries, the US defense-tech startup founded by Palmer Luckey, reached a $61 billion valuation following a fresh funding round co-led by Andreessen Horowitz and Thrive Capital on May 13, 2026.
- • The funding round raised approximately $4 billion, nearly doubling the company's previous valuation of approximately $30.5 billion, signaling strong investor confidence in the defense technology sector.
- • Andreessen Horowitz and Thrive Capital jointly led the investment, underscoring major venture capital commitment to autonomous defense systems and emerging military technology platforms.
- • The valuation milestone positions Anduril among the most valuable private defense-tech companies globally, reflecting accelerating demand for AI-driven autonomous systems in national security applications.
Summary
Palmer Luckey's Anduril, which focuses on autonomous defense systems and AI-driven military applications, has become a focal point for venture capital investment in the defense sector. The co-leadership of the funding round by both Andreessen Horowitz and Thrive Capital—two of the largest and most influential venture firms globally—signals broad institutional confidence in Anduril's technology platform and market positioning. The doubling of valuation in a single funding round demonstrates investor appetite for scaling autonomous defense capabilities amid evolving geopolitical conditions.
The $61 billion valuation positions Anduril as one of the highest-valued private defense-technology companies, reflecting both the capital intensity of the sector and the strategic importance assigned by investors to autonomous systems development. The timing of this funding round aligns with broader trends of increased defense spending and technology modernization across NATO and allied nations, creating favorable conditions for specialized defense-tech vendors. However, market analysis suggests potential IPO challenges ahead, with one source estimating a 19 percent probability of Anduril achieving a 2026 public offering, citing valuation gaps and regulatory uncertainty as key risk factors.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.